Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2005
12/15/2005WO2005117994A2 Bmp pathway methods and compositions
12/15/2005WO2005117993A2 Method of using adenoviral vectors with improved safety and efficacy for the treatment of cancer
12/15/2005WO2005117992A2 Controlled delivery of therapeutic compounds
12/15/2005WO2005117991A2 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
12/15/2005WO2005117990A2 Compositions and methods for treatment of vascular grafts
12/15/2005WO2005117989A1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance
12/15/2005WO2005117975A2 Methods for treating vascular disease
12/15/2005WO2005117974A2 Cancer treatment method by inhibiting mage gene expression or function
12/15/2005WO2005117947A1 Use of the foamy virus bet protein for inactivating apobec
12/15/2005WO2005117928A1 Compositions and methods for the treatment of skin cancer
12/15/2005WO2005117832A1 Liposomal assembly for therapeutic and/or diagnostic use
12/15/2005WO2005090570A9 Therapeutic compositions and methods for treating diseases that involve angiogenesis
12/15/2005WO2005084751A3 Implantable system for controlling gene expression
12/15/2005WO2005083126A3 Alterations of fibulin genes in macular degeneration
12/15/2005WO2005082396A3 Use of mda-7 to inhibit infection by pathogenic organisms
12/15/2005WO2005079848A3 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders
12/15/2005WO2005079506A3 Systemic immune activation method using nucleic acid-lipid complexes
12/15/2005WO2005070459A8 Method of continuing expression of vector repeatedly administered
12/15/2005WO2005062767A3 Hoxd3, hoxa3, and hoxb3 compositions and methods for improved wound healing
12/15/2005WO2005054485A3 Adenovirus-transfected primary cells and methods of pathway mapping
12/15/2005WO2005048914A3 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
12/15/2005WO2005046564A3 Diagnosis and treatment of liver fibrosis
12/15/2005WO2005007832A3 System for external control of oncolytic virus replication
12/15/2005WO2005001142A3 Methods and nucleic acids for the analysis of colorectal cell proliferative disorders
12/15/2005WO2004101764A3 Methods of modulating metastasis and skeletal related events resulting from metastases
12/15/2005WO2003087324A3 Antibody gene transfer and recombinant aav
12/15/2005WO2002083921A8 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
12/15/2005WO2002083855A3 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2005US20050277763 For cancer therapy
12/15/2005US20050277613 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases
12/15/2005US20050277612 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/15/2005US20050277611 Cationic cardiolipin analoges and its use thereof
12/15/2005US20050277610 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277608 Prevent, inhibit, or reduce hair growth, for hair removal or depilation; alopecia and atrichia
12/15/2005US20050277607 Compositions and methods for regulating peptidyltransferase activity and uses thereof
12/15/2005US20050277606 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death
12/15/2005US20050277605 Superior molecular vaccine based on self-replicating rna, suicidal dna or naked dna vector, that links antigen with polypeptide that promotes antigen presentation
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277603 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
12/15/2005US20050277575 Therapeutic compositions and methods for treating diseases that involve angiogenesis
12/15/2005US20050277194 Complementing cell lines
12/15/2005US20050277193 Vectors and methods for gene transfer
12/15/2005US20050277118 Methods for identifying subjects at risk of melanoma and treatments thereof
12/15/2005US20050276856 Non-aqueous single phase vehicles and formulations utilizing such vehicles
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050276809 comprising antibodies that specifically bind caspase-8 as inhibitors; cancer; activation of the receptor-interacting protein (RIP, a serine-threonine kinase) and Jun N-terminal kinase induce cell death with the morphology of autophagy
12/15/2005US20050276804 Method for preventing or treating cardiac hypertrophy
12/15/2005US20050276787 Adeno-associated vector compositions for expression of factor VIII
12/15/2005US20050276758 Method for screening agents against human prostate disease
12/15/2005DE10128980B4 Gen-modifizierte alloreaktive T-Zellen, Verfahren zu ihrer Herstellung und ihre Verwendung Gene-modified alloreactive T-cells, processes for their preparation and their use
12/15/2005CA2836987A1 Chimeric adenoviruses for use in cancer treatment
12/15/2005CA2569183A1 Methods and compositions for the inhibition of gene expression
12/15/2005CA2568838A1 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
12/15/2005CA2568781A1 Intrathymic administration of viral vectors for the induction of immune tolerance, the prevention or treatment of immunodeficiencies or autoimmune diseases
12/15/2005CA2568772A1 Expression system based on recombinant vesicular stomatitis virus synthesizing t7 rna polymerase
12/15/2005CA2568344A1 Novel artificial antigen presenting cells and uses therefor
12/15/2005CA2567526A1 Cancer treatment method by inhibiting mage gene expression or function
12/15/2005CA2567094A1 Chimeric adenoviruses for use in cancer treatment
12/15/2005CA2566571A1 Treatment methods utilizing albumin-binding proteins as targets
12/15/2005CA2565685A1 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
12/15/2005CA2564092A1 Methods and compositions for the treatment of polycystic diseases
12/15/2005CA2563930A1 Method for activating of t cell protein tyrosine phosphatase and therapeutical methods based thereon
12/14/2005EP1605055A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605054A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605053A1 Use of adenoviruses mutated in the VA genes for cancer treatment
12/14/2005EP1605045A2 Polypeptides and nucleic acids encoding same
12/14/2005EP1605042A2 Compositions for protein fragment complementation assays to detect biomolecular interactions
12/14/2005EP1604688A1 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy
12/14/2005EP1604674A2 Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence
12/14/2005EP1604036A2 Compositions and methods of using hexokinase v
12/14/2005EP1604012A2 METHODS AND COMPOSITIONS FOR SELECTIVE RNAi MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMAL CELLS
12/14/2005EP1604009A2 Method for identifying risk of melanoma and treatments thereof
12/14/2005EP1603951A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies
12/14/2005EP1603945A2 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
12/14/2005EP1603942A2 Regulation of gene expression
12/14/2005EP1603587A1 Use of tumor endothelial markers 1, 9 and 17 to promote angiogenesis
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1543324A4 Methods and compositions for grafting functional loops into a protein
12/14/2005EP1527084A4 Promoters exhibiting endothelial cell specificity and methods of using same
12/14/2005EP1438410B1 Promoters to control cell differentiation
12/14/2005EP1405074A4 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/14/2005EP1228209B1 "insulin-responsive sequence dna binding protein-1" (irsdbp-1), gene encoding it and uses thereof
12/14/2005EP1217989B1 Vaccines for oral use which contain liposome-entrapped dna
12/14/2005EP1127121B1 Construction d'une retrovirus exprimant le locus mel de streptomyces, et son expression dans des cellules mammiferes
12/14/2005EP1114160B1 Moraxella catarrhalis basb034 polypeptides and uses thereof
12/14/2005EP1007714B1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/14/2005EP0927045B1 Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/14/2005EP0831782B1 Methods and system for processing dispersible fine powders
12/14/2005EP0506830B1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
12/14/2005CN1706955A Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF
12/14/2005CN1706502A Antihypertensive nucleic acid vaccine and its prepn process
12/14/2005CN1231598C Process for recombining aviadenovirus
12/14/2005CN1231589C Eukaryotic gene expression cassette and uses thereof
12/14/2005CN1231578C Attenuated virus of ox's viral diarrhea
12/14/2005CN1231493C Amphoteric sterols and the use thereof
12/14/2005CN1231491C Mammal telomerase
12/14/2005CN1231257C Use of preparing medicine for raising genitality of female animals with long PENTRAXIN PTX 3
12/13/2005US6974867 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
12/13/2005US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases
1 ... 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 ... 870